{"id":"https://openalex.org/W2473040203","doi":null,"title":"Fc gamma-receptors in skin and serum from patients with psoriasis, before and after therapy.","display_name":"Fc gamma-receptors in skin and serum from patients with psoriasis, before and after therapy.","alternate_titles":[],"publication_year":1994,"publication_date":"1994-01-01","ids":{"openalex":"https://openalex.org/W2473040203","mag":"2473040203","pmid":"https://pubmed.ncbi.nlm.nih.gov/8073816"},"language":"en","primary_location":{"id":"pmid:8073816","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8073816","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta dermato-venereologica. Supplementum","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W2473040203"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110483422","display_name":"Jens Roar Bjerke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J R Bjerke","raw_affiliation_strings":["Department of Dermatology, Ullevaal Hospital, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Ullevaal Hospital, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081346529","display_name":"M Tiga\u0142onowa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M Tigalonova","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"T S Jensen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"T S Jensen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5109325943","display_name":"Roald Matre","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R Matre","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1312,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.37589904,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"186","issue":null,"first_page":"141","last_page":"142"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fc-gamma-receptor","display_name":"Fc gamma receptor","score":0.984000027179718},{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.8560000061988831},{"id":"https://openalex.org/keywords/plaque-psoriasis","display_name":"plaque psoriasis","score":0.7559999823570251},{"id":"https://openalex.org/keywords/immune-complexes","display_name":"immune complexes","score":0.671999990940094},{"id":"https://openalex.org/keywords/langerhans-cells","display_name":"Langerhans cells","score":0.9179999828338623},{"id":"https://openalex.org/keywords/keratinocytes","display_name":"keratinocytes","score":0.949999988079071},{"id":"https://openalex.org/keywords/cyclosporine","display_name":"cyclosporine","score":0.949999988079071},{"id":"https://openalex.org/keywords/acitretin","display_name":"acitretin","score":1.0},{"id":"https://openalex.org/keywords/high-affinity-ige-receptor","display_name":"high-affinity IgE receptor","score":0.5659999847412109},{"id":"https://openalex.org/keywords/fcrii","display_name":"FcRII","score":0.9919999837875366},{"id":"https://openalex.org/keywords/disease-activity","display_name":"disease activity","score":0.6169999837875366},{"id":"https://openalex.org/keywords/dermal-epidermal-junction","display_name":"basement membrane zone","score":0.9580000042915344}],"concepts":[{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.7972688674926758},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6350517868995667},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5725857615470886},{"id":"https://openalex.org/C163764329","wikidata":"https://www.wikidata.org/wiki/Q785022","display_name":"Autoantibody","level":3,"score":0.5053139328956604},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4776157736778259},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.42959412932395935},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3755311369895935},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3734711706638336}],"mesh":[{"descriptor_ui":"D004797","descriptor_name":"Enzyme-Linked Immunosorbent Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007158","descriptor_name":"Immunologic Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011961","descriptor_name":"Receptors, Fc","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D012867","descriptor_name":"Skin","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:8073816","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8073816","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta dermato-venereologica. Supplementum","raw_type":"Journal Article"},{"id":"mag:2473040203","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8073816","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2009383732","https://openalex.org/W2412404052","https://openalex.org/W2255379534","https://openalex.org/W4312194872","https://openalex.org/W2159520505","https://openalex.org/W1617920818","https://openalex.org/W200035220","https://openalex.org/W2151368570","https://openalex.org/W1437036725","https://openalex.org/W2258812954"],"abstract_inverted_index":{"IgG-Fc":[0],"receptors":[1],"(FcR)":[2],"are":[3],"present":[4],"on":[5,132],"most":[6],"immune":[7,39,92,127],"competent":[8],"cells.":[9],"We":[10],"have":[11],"examined":[12],"FcR":[13,34,41,108,130,148,176,185],"in":[14,42,46,111,152,157,186,194],"skin":[15,71,196],"lesions":[16,82],"from":[17,76,154],"8":[18,70],"patients":[19,26,49,174],"with":[20,27,52],"stationary":[21],"plaque":[22],"psoriasis":[23,30],"and":[24,35,61,73,89,91,102,126,140,146,166],"12":[25],"highly":[28],"active":[29,80],"using":[31],"MoAbs":[32],"against":[33],"binding":[36],"of":[37,143,184],"soluble":[38],"complexes.":[40],"serum":[43],"were":[44,50,99,122,150],"measured":[45],"ELISA.":[47],"The":[48,95,107,181],"treated":[51],"cyclosporin":[53],"(n":[54,58,64],"=":[55,59,65],"5),":[56],"acitretin":[57],"7)":[60],"Goeckerman":[62],"regimen":[63],"8).":[66],"As":[67],"controls":[68],"served":[69],"biopsies":[72],"22":[74],"sera":[75,153,188],"healthy":[77],"individuals.":[78],"Highly":[79],"psoriatic":[81,187],"showed":[83],"strongest":[84],"activity":[85,109,131,145],"for":[86,124],"FcRI,":[87],"II":[88],"III":[90],"complex":[93,128],"binding.":[94,129],"FcR+":[96],"mononuclear":[97],"cells":[98,120],"located":[100],"perivascularly":[101],"along":[103],"the":[104,114,175,195],"dermo-epidermal":[105],"junction.":[106],"decreased":[110,134],"correlation":[112],"to":[113,169,192],"improvement":[115],"following":[116],"therapy.":[117,136,147,180],"Epidermal":[118],"Langerhans":[119],"(LC)":[121],"positive":[123],"FcRII":[125],"LC":[133],"during":[135,179],"Keratinocytes":[137],"expressed":[138],"FcRI":[139],"III,":[141],"irrespective":[142],"disease":[144,170],"levels":[149,177,183],"lower":[151],"psoriatics":[155],"than":[156],"controls,":[158],"median":[159],"0.15":[160],"vs.":[161],"0.27":[162],"(p":[163],"<":[164],"0.01),":[165],"not":[167],"correlated":[168],"activity.":[171],"In":[172],"4":[173],"increased":[178],"reduced":[182],"might":[189],"be":[190],"due":[191],"consumption":[193],"or":[197],"anti-FcR":[198],"autoantibodies.":[199]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2473040203","counts_by_year":[],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-07-22T00:00:00"}
